Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | ALKBH3 | Q96Q83 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5887287 | 0.94 | ACHE (0.46) | ACHEHPGDNPC1RAB9AKMT2A | |
| SCHEMBL5887353 | 0.87 | MEN1 (0.35) | ACHEHSD17B10NPC1RAB9AKMT2A | |
| SCHEMBL6416879 | 0.85 | HPGD (0.32) | HPGDKMT2AALOX5 | |
| SCHEMBL5887285 | 0.84 | ALKBH3 (0.44) | ACHECYP2C9HPGDCYP2C19HSD17B10 | |
| SCHEMBL5887347 | 0.84 | MEN1 (0.35) | KMT2A | |
| SCHEMBL5887105 | 0.83 | ESR2 (0.35) | NPC1ALOX5 | |
| SCHEMBL6047646 | 0.82 | CYP2D6 (0.32) | CYP2D6CYP2C9HPGDALOX15CYP2C19 | |
| SCHEMBL5887426 | 0.81 | MEN1 (0.34) | CYP2D6CYP2C9HPGDALOX15CYP2C19 | |
| SCHEMBL4165222 | 0.79 | ALDH1A1 (0.31) | ACHE | |
| SCHEMBL5887073 | 0.79 | ACHE (0.47) | ACHEHPGDNPC1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7037931-B2 | Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-05-02 | — | — | US | claimed |
| JP-2006501194-A | — | — | 2006-01-12 | — | — | JP | claimed |
| EP-1525190-A1 | CCK-1 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-04-27 | — | — | EP | claimed |
| WO-2004007463-A1 | CCK-1 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2004-01-22 | — | — | WO | claimed |